HANMI PHARMACEUTICAL CO., LTD. enters APTOSE BIOSCIENCES INC. with 508.71K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/20/2025ACC: 0000899140-25-000440
10% Owner
Since Mar 2025
508.71K
Baseline shares
100% direct
508.71K
Direct ownership
1 position
77.97K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned508.71K
Total
508.71K direct508.71K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 508.71K | Direct |
| Total | 508.71K | 508.71K direct |
Derivative Holdings1
Warrants to Purchase Common Shares
DirectUnderlying security
Common Shares
Underlying shares
77.97K
Shares owned
N/A
Exercise price
51.3
Expiration
—
Exercise window
—
Total
Underlying
77.97K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrants to Purchase Common Shares Direct | Common Shares | 51.3 | — | — | 77.97K | N/A |
| Total | 77.97K | 0.00 | ||||